Clinical Trial

Resistance Training Adaptations and Caffeine Intake

Completed
View on ClinicalTrials.gov →
Summary
This parallel-group, randomized, double-blind, placebo-controlled trial investigates the effects of three different caffeine supplementation strategies on resistance training-induced adaptations in 120 caffeine-naive, inactive young adult males. Participants will undergo a 10-week supervised resistance training program. The four supplementation strategies are: (1) constant daily low-moderate dosing (4 mg/kg/day), (2) gradually escalating dose (2 to 6 mg/kg across weeks), (3) training-day-only caffeine (4 mg/kg/day), and (4) placebo. Primary outcomes include maximal strength, body composition (lean body mass and fat mass), skeletal muscle thickness, and training volume progression. Secondary outcomes include muscular endurance, jump height, flight-time-to-contraction-time (FT:CT) ratio, mechanistic/biological variables (epinephrine, norepinephrine, cortisol, testosterone, creatine kinase, IGF-1), rate of perceived exertion, sleep/recovery parameters, and adverse effects.
Protocol Amendment History 6 changes
critical Trial status changed: Not Yet Recruiting → Completed 2026-07-15
critical Primary endpoint(s) modified 2026-07-15
notable Enrollment reduced: 180 -> 120 participants 2026-07-15
minor Trial arms changed: 6 -> 4 2026-07-15
notable Primary completion pushed: 2026-04-20 -> 2026-05-30 2026-07-15
minor Completion pushed: 2026-04-20 -> 2026-06-07 2026-07-15
Trial Details
NCT Number NCT07410195
Lead Sponsor Istanbul University - Cerrahpasa
Collaborators: İstanbul Yeni Yüzyıl Üniversitesi
Conditions Muscle Hypotrophy, Exercise Performance, Muscle Strength, Adaptation
Enrollment 120 participants
Start Date 2026-02-20
Primary Completion 2026-05-30 (estimated)
Study Completion 2026-06-07 (estimated)
Updated on ClinicalTrials.gov 2026-07-14